BIO-TECHNE CEO Disposes of $144k in Stock for Tax Purposes
BIO-TECHNE Corp
Subscribe to track TECH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
BIO-TECHNE CEO Disposes of $144k in Stock for Tax Purposes
Company: BIO-TECHNE Corp (TECH) Form: 4 | Filed: 2025-11-05 Significance: Low
Insider: Kelderman Kim Title: Chief Executive Officer | Relationship: Director, Officer
Transaction: • Type: Tax Withholding • Shares: 2,303 • Price: $62.57 • Value: $144,099 • Owned After: 48,665
Key Insight: The CEO disposed of shares to cover tax liabilities (Transaction Code 'F'), a common and non-discretionary event with low market significance.
Market Context: This transaction represents a negligible fraction (<0.002%) of the company's $9.74 billion market capitalization and has no bearing on insider sentiment.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: BIO-TECHNE Corp (TECH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The CEO of BIO-TECHNE Corp executed a routine, non-discretionary disposition of shares to cover tax obligations, a transaction with minimal market impact.
- Market Impact: Neutral. This type of transaction is common and does not reflect a change in the insider's investment thesis.
Company Information
| Field | Value |
|---|---|
| Company | BIO-TECHNE Corp |
| Ticker Symbol | TECH |
| CIK | 0000842023 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Kelderman Kim |
| CIK | 0001739054 |
| Title/Position | Chief Executive Officer |
| Relationship | Director, Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | F - Payment of tax liability by withholding securities |
| Security Type | Common Stock |
| Shares Involved | 2,303 |
| Price Per Share | $62.57 |
| Total Value | $144,098.71 |
| Shares Owned After | 48,665 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $144,098.71 |
| % of Market Cap | 0.0015% |
| Shares Transacted | 2,303 |
| % of Shares Outstanding | 0.0015% |
| Post-Transaction Ownership | 48,665 shares (0.031% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $144k transaction is immaterial against BIO-TECHNE's $9.74 billion market capitalization.
- Ownership Concentration: The CEO's direct holdings remain minimal at 0.031% of total shares outstanding.
- Transaction Significance: The transaction's value is less than 0.01% of both market cap and shares outstanding, placing it firmly in the 'Low' significance category. It is a procedural financial management action, not a strategic trade.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Transaction code 'F' signifies a non-discretionary disposition to cover taxes, often related to the vesting of equity awards. It is not an open-market sale and carries no sentiment signal.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction is a withholding of shares and not an open market trade, so it will not directly impact trading volume.
- Sentiment Indicator: Neutral. This is a routine administrative action required for compensation and tax purposes.
Additional Context
Transaction Notes
- The transaction is coded 'F', which the SEC defines as "Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3." This confirms the non-discretionary nature of the disposal.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
